Elnusa Tbk PT
IDX:ELSA
Elnusa Tbk PT
IDX:ELSA
Price:
434
IDR
Market Closed
Market Cap:
3.2T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
ELSA Alert
Elnusa Tbk PT
434
0 (0%)
| 52 Week Range |
378
540
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Elnusa Tbk PT
Balance Sheet
Balance Sheet Decomposition
Elnusa Tbk PT
Elnusa Tbk PT
| Current Assets | 7.2T |
| Cash & Short-Term Investments | 2.7T |
| Receivables | 3.4T |
| Other Current Assets | 1.1T |
| Non-Current Assets | 3.2T |
| Long-Term Investments | 79B |
| PP&E | 2T |
| Intangibles | 6.1B |
| Other Non-Current Assets | 1.1T |
| Current Liabilities | 5.3T |
| Accounts Payable | 992.3B |
| Accrued Liabilities | 3.1T |
| Short-Term Debt | 844.5B |
| Other Current Liabilities | 373.2B |
| Non-Current Liabilities | 312.6B |
| Long-Term Debt | 200.3B |
| Other Non-Current Liabilities | 112.3B |
Balance Sheet
Elnusa Tbk PT
Elnusa Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
695 466
|
818 374
|
630 687
|
802 863
|
672 257
|
813 626
|
1 231 867
|
1 144 769
|
1 656 975
|
2 077 725
|
|
| Cash |
695 466
|
818 374
|
630 687
|
802 863
|
672 257
|
813 626
|
826 867
|
1 088 769
|
1 431 975
|
1 377 725
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
405 000
|
56 000
|
225 000
|
700 000
|
|
| Short-Term Investments |
369 822
|
122 819
|
124 164
|
105 148
|
60 727
|
72 992
|
29 613
|
45 082
|
40 616
|
36 447
|
|
| Total Receivables |
931 660
|
792 413
|
717 972
|
1 261 665
|
1 578 530
|
2 094 586
|
2 168 868
|
2 307 634
|
2 982 277
|
3 014 135
|
|
| Accounts Receivables |
921 008
|
777 067
|
713 885
|
1 258 525
|
1 571 843
|
2 089 958
|
2 150 154
|
2 287 925
|
2 919 355
|
3 011 104
|
|
| Other Receivables |
10 652
|
15 346
|
4 087
|
3 140
|
6 687
|
4 628
|
18 714
|
19 709
|
62 922
|
3 031
|
|
| Inventory |
114 830
|
127 890
|
130 532
|
96 508
|
167 065
|
213 298
|
273 488
|
322 656
|
429 814
|
452 691
|
|
| Other Current Assets |
124 890
|
217 823
|
261 761
|
113 281
|
679 928
|
503 868
|
513 489
|
626 643
|
177 334
|
525 303
|
|
| Total Current Assets |
2 236 668
|
2 079 319
|
1 865 116
|
2 379 465
|
3 158 507
|
3 698 370
|
4 217 325
|
4 446 784
|
5 287 016
|
6 106 301
|
|
| PP&E Net |
1 239 721
|
1 480 580
|
1 604 535
|
1 569 071
|
1 735 854
|
1 819 321
|
2 143 618
|
1 894 884
|
2 259 207
|
2 225 184
|
|
| PP&E Gross |
1 239 721
|
1 480 580
|
1 604 535
|
1 569 071
|
1 735 854
|
1 819 321
|
2 143 618
|
1 894 884
|
2 259 207
|
2 225 184
|
|
| Accumulated Depreciation |
2 033 754
|
2 246 041
|
2 436 552
|
2 700 209
|
2 969 730
|
3 169 203
|
3 739 093
|
4 234 529
|
4 279 136
|
4 773 124
|
|
| Intangible Assets |
15 187
|
20 352
|
21 699
|
14 091
|
12 042
|
7 926
|
2 950
|
10 285
|
3 298
|
2 243
|
|
| Note Receivable |
703
|
22 374
|
11 137
|
5 058
|
7 082
|
5 707
|
0
|
0
|
299 919
|
268 502
|
|
| Long-Term Investments |
53 363
|
90 650
|
119 492
|
92 748
|
114 249
|
402 324
|
397 010
|
400 764
|
81 828
|
89 336
|
|
| Other Long-Term Assets |
712 648
|
758 986
|
591 251
|
805 052
|
643 757
|
882 803
|
801 919
|
482 140
|
904 821
|
909 916
|
|
| Total Assets |
4 256 884
N/A
|
4 407 513
+4%
|
4 190 956
-5%
|
4 855 369
+16%
|
5 657 327
+17%
|
6 805 037
+20%
|
7 562 822
+11%
|
7 234 857
-4%
|
8 836 089
+22%
|
9 601 482
+9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
305 146
|
235 937
|
237 083
|
308 321
|
517 470
|
692 797
|
685 105
|
671 338
|
678 678
|
1 004 817
|
|
| Accrued Liabilities |
762 963
|
658 760
|
429 423
|
658 731
|
907 110
|
1 123 455
|
1 107 694
|
1 373 776
|
2 412 827
|
2 680 026
|
|
| Short-Term Debt |
0
|
218 293
|
486 500
|
695 012
|
608 865
|
309 302
|
110 714
|
167 975
|
128 258
|
171 231
|
|
| Current Portion of Long-Term Debt |
186 796
|
225 481
|
29 331
|
2 256
|
0
|
239 579
|
542 430
|
215 039
|
224 755
|
240 396
|
|
| Other Current Liabilities |
123 406
|
110 114
|
71 844
|
93 461
|
83 453
|
139 202
|
127 524
|
133 106
|
116 660
|
137 653
|
|
| Total Current Liabilities |
1 378 311
|
1 448 585
|
1 254 181
|
1 757 781
|
2 116 898
|
2 504 335
|
2 573 467
|
2 561 234
|
3 561 178
|
4 234 123
|
|
| Long-Term Debt |
248 868
|
295 954
|
33 939
|
0
|
212 550
|
578 159
|
1 100 312
|
748 949
|
1 051 958
|
831 590
|
|
| Minority Interest |
31 235
|
34 305
|
38 292
|
4 430
|
1 705
|
1 660
|
1 508
|
1 609
|
1 586
|
1 588
|
|
| Other Liabilities |
80 249
|
27 788
|
25 093
|
45 668
|
27 679
|
145 845
|
148 097
|
146 540
|
105 742
|
119 701
|
|
| Total Liabilities |
1 738 663
N/A
|
1 806 632
+4%
|
1 351 505
-25%
|
1 807 879
+34%
|
2 358 832
+30%
|
3 229 999
+37%
|
3 823 384
+18%
|
3 458 332
-10%
|
4 720 464
+36%
|
5 187 002
+10%
|
|
| Equity | |||||||||||
| Common Stock |
729 850
|
729 850
|
729 850
|
729 850
|
729 850
|
729 850
|
729 850
|
729 850
|
729 850
|
729 850
|
|
| Retained Earnings |
1 414 267
|
1 500 931
|
1 722 099
|
1 938 147
|
2 177 390
|
2 464 785
|
2 625 222
|
2 659 237
|
2 982 928
|
3 297 025
|
|
| Additional Paid In Capital |
431 422
|
431 422
|
431 422
|
435 688
|
435 691
|
435 691
|
435 691
|
435 691
|
435 691
|
435 691
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
57 318
|
61 322
|
43 920
|
56 195
|
44 436
|
55 288
|
51 325
|
48 253
|
32 844
|
48 086
|
|
| Total Equity |
2 518 221
N/A
|
2 600 881
+3%
|
2 839 451
+9%
|
3 047 490
+7%
|
3 298 495
+8%
|
3 575 038
+8%
|
3 739 438
+5%
|
3 776 525
+1%
|
4 115 625
+9%
|
4 414 480
+7%
|
|
| Total Liabilities & Equity |
4 256 884
N/A
|
4 407 513
+4%
|
4 190 956
-5%
|
4 855 369
+16%
|
5 657 327
+17%
|
6 805 037
+20%
|
7 562 822
+11%
|
7 234 857
-4%
|
8 836 089
+22%
|
9 601 482
+9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
7 299
|
7 299
|
7 299
|
7 299
|
7 299
|
7 299
|
7 299
|
7 299
|
7 299
|
7 299
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
